| ²é¿´: 590 | »Ø¸´: 3 | |||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | |||
pawpawer1984гæ (СÓÐÃûÆø)
|
[ÇóÖú]
surrogate endpoints ÈçºÎ·Ò룬ҩѧÏà¹Ø
|
||
|
Àý¾äÈçÏ£º We assessed the feasibility of administering a neuroprotective drug, vigabatrin (VGB; gamma-vinyl-gamma-aminobutyric acid) with multimodality monitoring, including cerebral microdialysis, in severe head injury patients, to measure surrogate endpoints and blood-brain barrier (BBB) penetration. |
» ÊÕ¼±¾ÌûµÄÌÔÌûר¼ÍƼö
¾«Æ··Ò뼯½õ |
» ²ÂÄãϲ»¶
²ÄÁÏѧ˶333Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
289Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
ÊÕ08µ÷¼ÁÉú
ÒѾÓÐ6È˻ظ´
²ÄÁÏר˶ÕÒµ÷¼Á
ÒѾÓÐ5È˻ظ´
085602 289·ÖÇóµ÷¼Á
ÒѾÓÐ5È˻ظ´
»¯¹¤×¨Ë¶Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
274Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
µ÷¼Á
ÒѾÓÐ3È˻ظ´
08¹¤Ñ§µ÷¼Á
ÒѾÓÐ15È˻ظ´
ÕÐ08¿¼Êýѧ
ÒѾÓÐ16È˻ظ´

Justain
гæ (³õÈëÎÄ̳)
- ·ÒëEPI: 7
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 185
- Ìû×Ó: 16
- ÔÚÏß: 3.6Сʱ
- ³æºÅ: 1738962
- ×¢²á: 2012-04-05
- רҵ: Íâ¹úÓïÑÔ
2Â¥2012-04-10 13:08:23
ade4502
½ð³æ (СÓÐÃûÆø)
- ·ÒëEPI: 1
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 723.9
- ºì»¨: 3
- Ìû×Ó: 135
- ÔÚÏß: 59.3Сʱ
- ³æºÅ: 948646
- ×¢²á: 2010-01-26
- ÐÔ±ð: MM
- רҵ: ¿¹Ö×ÁöÒ©ÎïÒ©Àí
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï
Mally89: ½ð±Ò+1, ¸ÐлӦÖú£¡~»¶Ó³£À´£¡~ºÃÔË£¡~\(^o^)/~ 2012-04-14 13:04:01
sltmac: ½ð±Ò+3, ·ÒëEPI+1 2012-04-26 10:43:05
Mally89: ½ð±Ò+1, ¸ÐлӦÖú£¡~»¶Ó³£À´£¡~ºÃÔË£¡~\(^o^)/~ 2012-04-14 13:04:01
sltmac: ½ð±Ò+3, ·ÒëEPI+1 2012-04-26 10:43:05
|
Ìæ´úÖյ㣺¾ßÓпÉÒÔÌæ´úÁÙ´²ÖÕµãµÄÒâÏòµÄÉúÎï±ê¼ÇÎï¡£Ìæ´úÖÕµãÓ¦¸ÃÄܹ»»ùÓÚÁ÷Ðв¡Ñ§¡¢ÖÎÁÆÑ§¡¢²¡ÀíÉúÀíѧ»òÆäËû¿ÆÑ§Ö¤¾Ý£¬À´Ô¤²âÁÙ´²»ñÒæ£¨»òËðÉË£¬»ò»ñÒæ/ËðÉ˲»×㣩¡£ ÏêϸÐÅÏ¢¿É²Î¿¼https://muchong.com/bbs/viewthread.php?tid=4365217 |
» ±¾ÌûÒÑ»ñµÃµÄºì»¨£¨×îÐÂ10¶ä£©

3Â¥2012-04-10 13:54:54
pawpawer1984
гæ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 1998.8
- É¢½ð: 5
- Ìû×Ó: 55
- ÔÚÏß: 10.5Сʱ
- ³æºÅ: 1550346
- ×¢²á: 2011-12-24
- ÐÔ±ð: GG
- רҵ: ÁÙ´²Ò©Àí

4Â¥2012-04-11 11:36:29













»Ø¸´´ËÂ¥
pawpawer1984